TELO

Telomir Pharmaceuticals, Inc. TELO

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$3.80M total
VANGUARD CAPITAL MANAGEMENT LLC
$2.07M+62.1%
GEODE CAPITAL MANAGEMENT, LLC
$433.9K+36.0%
BlackRock, Inc.
$359.0K-3.0%
VANGUARD FIDUCIARY TRUST CO
$288.4K+66.2%
NORTHERN TRUST CORP
$78.8K+47.1%
STATE STREET CORP
$75.0K0.0%
Bank of New York Mellon Corp
$65.9K0.0%
CAPTRUST FINANCIAL ADVISORS
$65.5KNew
OSAIC HOLDINGS, INC.
$53.1K+15.9%
World Investment Advisors
$48.1K0.0%
OneDigital Investment Advisors LLC
$29.4K0.0%
Qube Research & Technologies Ltd
$27.9KNew
Praetorian Wealth Management, Inc.
$25.6K0.0%
Virtu Financial LLC
$22.0KNew
Vestmark Advisory Solutions, Inc.
$17.4K+3.8%
CITADEL ADVISORS LLC
$17.0KNew
Morton Capital Management LLC/CA
$16.2K0.0%
TWO SIGMA SECURITIES, LLC
$16.1KNew
Clearstead Advisors, LLC
$16.0K0.0%
NorthCrest Asset Manangement, LLC
$15.4KNew
KESTRA PRIVATE WEALTH SERVICES, LLC
$14.1K0.0%
REGIONS FINANCIAL CORP
$13.6K0.0%
UBS Group AG
$10.2K-13.6%
Tower Research Capital LLC (TRC)
$10.1KNew
Vanguard Global Advisers, LLC
$8.4K0.0%
See all 33 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TELO

Earnings Per Share

13fpro.ai/company/TELO

Loading ratio trend…

TELO insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Telomir Pharmaceuticals, Inc. (TELO): stock profile, AI score and financials

Telomir Pharmaceuticals, Inc. (TELO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TELO is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of TELO by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, BlackRock, based on the most recent SEC filings. TELO trades on the Nasdaq exchange and files with the SEC under CIK 1971532. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TELO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Telomir Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1971532 →